Comparison of adverse reactions of two rabies vaccine
Phase 1
Completed
- Conditions
- Rabies.animal bites
- Registration Number
- IRCT2015102124470N1
- Lead Sponsor
- Center of Disease Control (CDC), Ministry of Health, Tehran, Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1800
Inclusion Criteria
inclusion criteria: age between 5 and 55 years; volunteer to participate in the study.
exclusion criteria: have a history of previous animal bites; receiving immunization against rabies previously; have a significant acute or chronic infectious disease; receiving transfusion with blood or blood products within the past month; concomitantly receiving corticosteroids or immunosuppressive drug therapy; have axillary temperature 37.5°C before injection; being pregnant in females
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ymphadenopathy. Timepoint: 30 minutes after each injection. Method of measurement: By physician.;Bruising. Timepoint: 30 minutes after each injection. Method of measurement: By physician.;Ittching. Timepoint: 30 minutes after each injection. Method of measurement: By physician.;Abscesses. Timepoint: 30 minutes after each injection. Method of measurement: b.;Erythema. Timepoint: 30 minutes after each injection. Method of measurement: By physician.;Swelling. Timepoint: 30 minutes after each injection. Method of measurement: By physician.
- Secondary Outcome Measures
Name Time Method Dizziness. Timepoint: 3 day after each injection. Method of measurement: evaluate by the patirnt.;Stomach ache. Timepoint: 3 day after each injection. Method of measurement: evaluate by the patirnt.;Nausea. Timepoint: 3 day after each injection. Method of measurement: evaluate by the patirnt.;Weakness. Timepoint: 3 day after each injection. Method of measurement: evaluate by the patirnt.;Muscle aches. Timepoint: 3 day after each injection. Method of measurement: evaluate by the patirnt.;Fever. Timepoint: 3 days after each injection. Method of measurement: evaluated daily by patients.;Vomiting. Timepoint: 3 day after each injection. Method of measurement: evaluate by the patirnt.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms underlying adverse reactions to PCEC and VERO rabies vaccines in post-exposure prophylaxis?
How does the safety profile of purified chick embryo cell vaccine compare to vero cell rabies vaccine in post-exposure rabies prevention?
Which biomarkers could predict differential immune responses to PCEC and VERO rabies vaccines in animal bite patients?
What are the comparative effectiveness and adverse event management strategies for PCEC and VERO vaccines in rabies post-exposure protocols?
Are there alternative rabies vaccine platforms or combination approaches that improve safety over PCEC and VERO vaccines in post-exposure settings?